Common use of Standstill on Other Regents IP Clause in Contracts

Standstill on Other Regents IP. The parties are also actively discussing Licensee’s request to incorporate the UCLA Case Numbers identified in the table below as Patent Rights licensed under the Agreement (“Potential Patent Rights”). To enable the parties to have additional time to negotiate the terms related thereto, The Regents agrees to not grant any option or license to its interest in the Potential Patent Rights to another person or entity for the period commencing on the First Amendment’s Effective Date and ending six (6) months thereafter. For clarity, no option or license is granted by The Regents to such Potential Patent Rights pursuant to this First Amendment. [***] Both The Regents and Licensee have executed this First Amendment by their authorized officers on the dates written below: KATMAI PHARMACEUTICALS, INC. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA By: /s/ Xxxxxxx Xxxxxx By: /s/ Xxxx Xxxxxxx (Signature) (Signature) Name: Xxxxxxx Xxxxxx Name: Xxxx Xxxxxxx Title: President and CEO Title: Associate Vice Chancellor, CEO & President Date: 12/18/2020 Date: 12/21/2020 EXHIBIT 1 [INSERT NUMBER] AMENDMENT TO EXCLUSIVE AGREEMENT [***] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SECOND AMENDMENT TO EXCLUSIVE AGREEMENT UC Control No. [***] THIS SECOND AMENDMENT (the “Second Amendment”) is effective this April 1, 2021, by and between The Regents of the University of California (“The Regents”), a California corporation having its statewide administrative offices at 0000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxxx, Xxxxxxxxxx 00000-0000, acting through the offices of The University of California, Los Angeles located at 00000 Xxxxxxxx Xxxx, Xxxxx 000, Xxx Xxxxxxx, XX 00000-0000, and Katmai Pharmaceuticals, Inc. (“Licensee”), a Delaware corporation having a principal place of business at 0000 Xxxxxxxxx Xxx., Xxxxxx Xxx Xxx, Xxxxxxxxxx 00000, amends that certain Exclusive License Agreement, UC Control No. 0000-00-0000, dated March 11, 2020, and as subsequently amended in a First Amendment effective December 21, 2020 (“First Amendment”) in accordance with the terms and conditions of this Second Amendment (collectively, the “Agreement”).